scholarly journals Tobacco Use in Adults With Mental Illness: An Overview of One State-Wide Tobacco Cessation Program

2018 ◽  
Vol 14 (2) ◽  
pp. 132-137
Author(s):  
Noeen Sarfraz ◽  
Yvon Fils-Aime ◽  
Michael Brand ◽  
Sara Vesely ◽  
Laura Beebe
Keyword(s):  
Mental Illness ◽  
General Population ◽  
Psychiatric Disorders ◽  
Tobacco Use ◽  
Tobacco Cessation ◽  
Vital Signs ◽  
The United States ◽  
Tobacco Marketing ◽  
Current Cigarette ◽  
Adults With Mental Illness

Even though one of the public health's top achievements of the 20th century involves tobacco cessation, a disproportionate burden of tobacco-related comorbidity still affects those with mental illness (Centers for Disease Control and Prevention, 2017; Cook et al., 2014). There is evidence suggesting that psychiatric disorders are associated with an increased prevalence in cigarette smoking (Tsoi, Porwa, & Webster, 2013). One explanation for this is the potentiating effect of nicotine on dopamine receptors (Mao, Gallagher, & McGehee, 2011). Other explanations include poverty, educational advancement and industry bias in tobacco marketing (MMWR Vital Signs: Current Cigarette, 2016; CDC Morbidity and Mortality, 2013). We know that adults with mental illness smoke at rates twice that of the general population, and are nicotine-dependent at rates up to three times higher than the general population (Cook et al., 2014; Grant, Hasin, Chou, Stinson, & Dawson, 2004). Adults with mental illness comprise about 19% of the population, but smoke approximately one-third of all the cigarettes smoked (MMWR Vital Signs: Current Cigarette, 2016). In the United States, the national tobacco use prevalence is estimated at 19%; however, prevalence among those with bipolar disorder is 51%–70% and 36%–80% among those with major depressive disorder (Grant et al., 2004; King, Dube, & Tynan, 2012; Lasser et al., 2000). Despite these high rates, recent studies suggest that smokers with mental illness are highly motivated to quit (Cook et al., 2014). However, it remains rare for mental and behavioural health professionals to offer tobacco cessation pharmacotherapy and counselling to clients with psychiatric disorders.

scholarly journals Seven Tips Mental Health Care Providers Can Use to Address Patient Tobacco Use

2021 ◽  
Vol 18 (7) ◽  
Author(s):  
Colleen E. McKay
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
General Population ◽  
Tobacco Use ◽  
Health Care Providers ◽  
The United States ◽  
Care Providers ◽  
Quit Smoking ◽  
Disproportionate Number ◽  
The U.S

Approximately fifty million people living in the United States (U.S.) use tobacco. Tobacco use is the single largest preventable cause of disease and/or death in the U.S. People living with mental illness account for a disproportionate amount of tobacco use. Individuals living with mental health or substance use conditions consume almost half of all cigarettes sold in the U.S. People with schizophrenia are three to four times as likely to smoke as the general population. People living with mental illness also die prematurely compared to the general population and they and have a disproportionate number of tobacco-attributable deaths. Less than two-thirds of psychiatrists ask about tobacco use and screening for tobacco use is not standard practice in many community-based services for mental health. Despite this, approximately 70% of people living with mental illness who smoke say they would like to quit smoking. This tip sheet offers 7 tips to help your clients quit using tobacco.

scholarly journals Prevalence and determinants of tobacco use amongst South African adults with mental illness in the Eastern Cape

2021 ◽  
Vol 27 ◽  
Author(s):  
Linda K. Tindimwebwa ◽  
Anthony I. Ajayi ◽  
Oladele V. Adeniyi
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
General Population ◽  
Tobacco Use ◽  
Depressive Disorders ◽  
Smoking Prevention ◽  
Eastern Cape ◽  
Physical And Mental Health ◽  
Cross Sectional ◽  
Tobacco Products

Background: Given the physical and mental health consequences of tobacco use amongst individuals with mental illness, it was imperative to assess the burden of tobacco use in this population.Aim: This study examined the patterns and factors associated with tobacco use in individuals attending the outpatient unit.Setting: Cecilia Makiwane Hospital Mental Health Department in Eastern Cape province, South Africa.Methods: Lifetime (ever use) use and current use of any tobacco products were examined in a cross-sectional study of 390 individuals between March and June 2020. A logistic regression was fitted to determine the correlates of lifetime and current use of any tobacco products.Results: The rates of ever use and current use of tobacco products were 59.4% and 44.6%, respectively. Of the participants interviewed, lifetime tobacco use was more prevalent amongst individuals with schizophrenia (67.9%) and cannabis-induced disorders (97.3%) and lower in those with major depressive disorders (36.1%) and bipolar and related disorders (43.5%). Men were six times more likely to have ever used or currently use tobacco products in comparison to women. Also, those who had a salaried job or owned a business were over three times more likely to have ever used or currently use tobacco products compared with those receiving government social grants.Conclusions: The prevalence of tobacco use in this study was significantly higher than the general population in the Eastern Cape. Therefore, smoking prevention and cessation interventions targeted at the general population should target this often neglected sub-population in the region.

scholarly journals Looking Back and Ahead: The Food and Drug Administration’s Regulation of the Tobacco Industry and Next-Generation Products

2019 ◽  
Vol 30 (1) ◽  
pp. 22-25 ◽  
Author(s):  
M. Jacob
Keyword(s):  
Oral Health ◽  
Oral Cavity ◽  
Tobacco Use ◽  
Tobacco Industry ◽  
The United States ◽  
Oral Disease ◽  
Next Generation ◽  
Long Term Effects ◽  
Tobacco Products ◽  
Tobacco Marketing

Regulatory policy toward tobacco significantly affects oral health because tobacco use is a driver of diseases that manifest themselves in or near the oral cavity. Tobacco use in the United States has been associated with millions of cases of periodontal disease. Researchers have identified the role of combusted and noncombusted tobacco products in promoting cancers of the head and neck, leading to disease and premature death. Tobacco companies have moved increasingly toward so-called next-generation products (NGPs)—products that may emit fewer toxins than combustible forms of tobacco. Although NGPs may negatively affect the lungs and other bodily systems, they shift the injection site of nicotine from the lungs to the oral cavity and oral tissues. Because the long-term effects of NGPs are unknown, this tobacco marketing development has profound implications for oral disease. The US Food and Drug Administration exercises regulatory authority over tobacco products. The tobacco industry has avoided meaningful regulation of its products, especially smokeless forms. By publishing new research, oral health scientists can meaningfully shape the climate in which the administration’s policy making occurs.

scholarly journals Engagement With Online Tobacco Marketing Among Adolescents in the United States: 2013–2014 to 2014–2015

2018 ◽  
Vol 21 (7) ◽  
pp. 918-925 ◽  
Author(s):  
Samir Soneji ◽  
JaeWon Yang ◽  
Meghan Bridgid Moran ◽  
Andy S L Tan ◽  
James Sargent ◽  
...  
Keyword(s):  
United States ◽  
Tobacco Use ◽  
Social Networking Sites ◽  
The United States ◽  
Health Study ◽  
Tobacco Marketing ◽  
The Past ◽  
Nationally Representative ◽  
National Prevalence ◽  
Over Time

Abstract Objective To assess changes in engagement with online tobacco and electronic cigarette (e-cigarette) marketing (online tobacco marketing) among adolescents in the United States between 2013 and 2015. Methods We assessed the prevalence of six forms of engagement with online tobacco marketing, both overall and by brand, among adolescents sampled in Wave 1 (2013–2014; n = 13651) and Wave 2 (2014–2015; n = 12172) of the nationally representative Population Assessment for Tobacco and Health Study. Engagement was analyzed by tobacco use status: non-susceptible never tobacco users; susceptible never tobacco users; ever tobacco users, but not within the past year; and past-year tobacco users. Results Among all adolescents, the estimated prevalence of engagement with at least one form of online tobacco marketing increased from 8.7% in 2013–2014 to 20.9% in 2014–2015. The estimated prevalence of engagement also increased over time across all tobacco use statuses (eg, from 10.5% to 26.6% among susceptible adolescents). Brand-specific engagement increased over time for cigarette, cigar, and e-cigarette brands. Conclusion Engagement with online tobacco marketing, both for tobacco and e-cigarettes, increased almost twofold over time. This increase emphasizes the dynamic nature of online tobacco marketing and its ability to reach youth. The Food and Drug Administration, in cooperation with social networking sites, should consider new approaches to regulate this novel form of marketing. Implications This is the first study to estimate the national prevalence of engagement with online tobacco marketing among adolescents over time. The estimated prevalence of this engagement approximately doubled between 2013–2014 and 2014–2015 among all adolescents and, notably, among adolescents at relatively low risk to initiate tobacco use. This increase in engagement could represent public health harm if it results in increased initiation and use of tobacco products. Stronger federal regulation of online tobacco marketing and tighter control of access to tobacco-related content by social media sites could reduce adolescents’ exposure to and engagement with online tobacco marketing.

scholarly journals HIV Testing Among Adults with Mental Illness in the United States

2014 ◽  
Vol 28 (12) ◽  
pp. 628-634 ◽  
Author(s):  
Baligh R. Yehia ◽  
Wanjun Cui ◽  
William W. Thompson ◽  
Matthew M. Zack ◽  
Lela McKnight-Eily ◽  
...  
Keyword(s):  
United States ◽  
Mental Illness ◽  
Hiv Testing ◽  
The United States ◽  
Adults With Mental Illness

scholarly journals Smoking, Mental Illness, and Public Health

2017 ◽  
Vol 38 (1) ◽  
pp. 165-185 ◽  
Author(s):  
Judith J. Prochaska ◽  
Smita Das ◽  
Kelly C. Young-Wolff
Keyword(s):  
Public Health ◽  
Mental Illness ◽  
Tobacco Use ◽  
Health Care Systems ◽  
The United States ◽  
User Characteristics ◽  
People With Mental Illness ◽  
Smoking Policies ◽  
High Smoking Prevalence ◽  
Care Systems

Tobacco use remains the leading preventable cause of death worldwide. In particular, people with mental illness are disproportionately affected with high smoking prevalence; they account for more than 200,000 of the 520,000 tobacco-attributable deaths in the United States annually and die on average 25 years prematurely. Our review aims to provide an update on smoking in the mentally ill. We review the determinants of tobacco use among smokers with mental illness, presented with regard to the public health HAVE framework of “the host” (e.g., tobacco user characteristics), the “agent” (e.g., nicotine product characteristics), the “vector” (e.g., tobacco industry), and the “environment” (e.g., smoking policies). Furthermore, we identify the significant health harms incurred and opportunities for prevention and intervention within a health care systems and larger health policy perspective. A comprehensive effort is warranted to achieve equity toward the 2025 Healthy People goal of reducing US adult tobacco use to 12%, with attention to all subgroups, including smokers with mental illness.

scholarly journals Tobacco Use and Associated Factors in Patients Presenting to a Psychiatric Emergency Room

2018 ◽  
Vol 2018 ◽  
pp. 1-5 ◽  
Author(s):  
Ashely Collins ◽  
Oluwadamilare Ajayi ◽  
Savannah Diamond ◽  
William Diamond ◽  
Suzanne Holroyd
Keyword(s):  
Mental Illness ◽  
Substance Use ◽  
Alcohol Use ◽  
General Population ◽  
Emergency Room ◽  
Tobacco Use ◽  
Associated Factors ◽  
Alcohol Use Disorders ◽  
Psychiatric Emergency ◽  
Psychiatric Emergency Room

Background. Rates of cigarette smoking among the public and individuals with mental illness have been well documented. Studies have demonstrated that prevalence of smoking among individuals with mental illness remains elevated compared to the general population and as a distinct subgroup, individuals with mental illness consume more than a third of cigarettes sold in the U.S. However, information on rates of smoking among patients presenting to a psychiatric emergency room (ER) is lacking. This study assesses this understudied population for smoking prevalence and associated factors. Methods. A retrospective chart review of 203 distinct psychiatric ER patients was conducted. Demographics, tobacco use, substance use, psychiatric diagnoses, and family history were noted and analyzed with SPSS. Result. Tobacco use rates were noted to be nearly fifty percent and significant associations were found with active suicidal ideation, alcohol use disorders, illicit drug use disorders, and history of prior psychiatric hospitalization. Conclusion. Tobacco use among psychiatric ER patients is much higher than that of the general population and associated with active suicidal ideations, alcohol use disorders, and illicit substance use disorders. These findings should be considered in the evaluation and expectant management of these patients by their clinicians and healthcare providers.

Applying the Transtheoretical Model to Tobacco Cessation and Prevention: A Review of Literature

2002 ◽  
Vol 17 (1) ◽  
pp. 7-71 ◽  
Author(s):  
Leslie Spencer ◽  
Francie Pagell ◽  
Maria Elena Hallion ◽  
Troy B. Adams
Keyword(s):  
Tobacco Use ◽  
Transtheoretical Model ◽  
Tobacco Cessation ◽  
Population Studies ◽  
The United States ◽  
The Body ◽  
Research Quality ◽  
Special Populations ◽  
Original Research ◽  
Research Questions

Objective. To comprehensively review all published, peer-reviewed research on the Transtheoretical Model (TTM) and tobacco cessation and prevention by exploring the validity of its constructs, the evidence for use of interventions based on the TTM, the description of populations using TTM constructs, and the identification of areas for further research. The three research questions answered were: “How is the validity of the TTM as applied to tobacco supported by research?” “How does the TTM describe special populations regarding tobacco use?” “What is the nature of evidence supporting the use of stage-matched tobacco interventions?” Data Source. Computer Database search (PsychInfo, Medline, Current Contents, ERIC, CINAHL-Allied Health, and Pro-Quest Nursing) and manual journal search. Inclusion/Exclusion Criteria. All English, original, research articles on the TTM as it relates to tobacco use published in peer-reviewed journals prior to March 1, 2001, were included. Commentaries, editorials, and books were not included. Data Extraction and Synthesis. Articles were categorized as TTM construct validation, population descriptions using TTM constructs, or intervention evaluation using TTM constructs. Summary tables including study design, research rating, purpose, methods, findings, and implications were created. Articles were further divided into groups according to their purpose. Considering both the findings and research quality of each, the three research questions were addressed. Results. The 148 articles reviewed included 54 validation studies, 73 population studies, and 37 interventions (some articles fit two categories). Overall, the evidence in support of the TTM as applied to tobacco use was strong, with supportive studies being more numerous and of a better design than nonsupportive studies. Using established criteria, we rated the construct validity of the entire body of literature as good; however, notable concerns exist about the staging construct. A majority of stage-matched intervention studies provided positive results and were of a better quality than those not supportive of stage-matched interventions; thus, we rated the body of literature using stage-matched tobacco interventions as acceptable and the body of literature using non–stage-matched interventions as suggestive. Population studies indicated that TTM constructs are applicable to a wide variety of general and special populations both in and outside of the United States, although a few exceptions exist. Conclusions. Evidence for the validity of the TTM as it applies to tobacco use is strong and growing; however, it is not conclusive. Eight different staging mechanisms were identified, raising the question of which are most valid and reliable. Interventions tailored to a smoker's stage were successful more often than nontailored interventions in promoting forward stage movement. Stage distribution is well-documented for U.S. populations; however, more research is needed for non-U.S. populations, for special populations, and on other TTM constructs.

Sign in / Sign up

Export Citation Format

Share Document